GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy
Haruka Miyata, Yoshihiko Hirohashi, Shuhei Yamada, Junko Yanagawa, Aiko Murai, Shinichi Hashimoto, Serina Tokita, Kanta Hori, Takashige Abe, Terufumi Kubo, Tomohide Tsukahara, Takayuki Kanaseki, Nobuo Shinohara, Toshihiko Torigoe
Topics & Concepts
Antigenclone (Java method)BiologyCancer researchCancer stem cellCytotoxic T cellCancer immunotherapyImmunotherapyStem cellTumor antigenImmunologyImmune systemCell biologyGeneticsGeneIn vitroImmunotherapy and Immune ResponsesBladder and Urothelial Cancer TreatmentsCancer Cells and Metastasis